Literature DB >> 24995796

Geminin loss causes neural tube defects through disrupted progenitor specification and neuronal differentiation.

Ethan S Patterson1, Laura E Waller1, Kristen L Kroll2.   

Abstract

Geminin is a nucleoprotein that can directly bind chromatin regulatory complexes to modulate gene expression during development. Geminin knockout mouse embryos are preimplantation lethal by the 32-cell stage, precluding in vivo study of Geminin's role in neural development. Therefore, here we used a conditional Geminin allele in combination with several Cre-driver lines to define an essential role for Geminin during mammalian neural tube (NT) formation and patterning. Geminin was required in the NT within a critical developmental time window (embryonic day 8.5-10.5), when NT patterning and closure occurs. Geminin excision at these stages resulted in strongly diminished expression of genes that mark and promote dorsal NT identities and decreased differentiation of ventral motor neurons, resulting in completely penetrant NT defects, while excision after embryonic day 10.5 did not result in NT defects. When Geminin was deleted specifically in the spinal NT, both NT defects and axial skeleton defects were observed, but neither defect occurred when Geminin was excised in paraxial mesenchyme, indicating a tissue autonomous requirement for Geminin in developing neuroectoderm. Despite a potential role for Geminin in cell cycle control, we found no evidence of proliferation defects or altered apoptosis. Comparisons of gene expression in the NT of Geminin mutant versus wild-type siblings at embryonic day 10.5 revealed decreased expression of key regulators of neurogenesis, including neurogenic bHLH transcription factors and dorsal interneuron progenitor markers. Together, these data demonstrate a requirement for Geminin for NT patterning and neuronal differentiation during mammalian neurulation in vivo.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromatin; Neural tube defect; Neuroepithelium; Neurogenesis

Mesh:

Substances:

Year:  2014        PMID: 24995796      PMCID: PMC4134736          DOI: 10.1016/j.ydbio.2014.06.021

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  77 in total

1.  Control of neurulation by the nucleosome assembly protein-1-like 2.

Authors:  U C Rogner; D D Spyropoulos; N Le Novère; J P Changeux; P Avner
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

2.  Wnt canonical pathway restricts graded Shh/Gli patterning activity through the regulation of Gli3 expression.

Authors:  Roberto Alvarez-Medina; Jordi Cayuso; Tadashi Okubo; Shinji Takada; Elisa Martí
Journal:  Development       Date:  2007-12-05       Impact factor: 6.868

3.  Geminin promotes neural fate acquisition of embryonic stem cells by maintaining chromatin in an accessible and hyperacetylated state.

Authors:  Dhananjay Yellajoshyula; Ethan S Patterson; Matthew S Elitt; Kristen L Kroll
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

4.  Folic acid prevents exencephaly in Cited2 deficient mice.

Authors:  Juan Pedro Martinez Barbera; Tristan A Rodriguez; Nicholas D E Greene; Wolfgang J Weninger; Antonio Simeone; Andrew J Copp; Rosa S P Beddington; Sally Dunwoodie
Journal:  Hum Mol Genet       Date:  2002-02-01       Impact factor: 6.150

5.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

Review 6.  The genetic basis of mammalian neurulation.

Authors:  Andrew J Copp; Nicholas D E Greene; Jennifer N Murdoch
Journal:  Nat Rev Genet       Date:  2003-10       Impact factor: 53.242

Review 7.  Development of the vertebrate central nervous system: formation of the neural tube.

Authors:  Nicholas D E Greene; Andrew J Copp
Journal:  Prenat Diagn       Date:  2009-04       Impact factor: 3.050

8.  Modifier locus for exencephaly in Cecr2 mutant mice is syntenic to the 10q25.3 region associated with neural tube defects in humans.

Authors:  Courtney E Davidson; Qian Li; Gary A Churchill; Lucy R Osborne; Heather E McDermid
Journal:  Physiol Genomics       Date:  2007-07-10       Impact factor: 3.107

9.  Polycomb-group complex 1 acts as an E3 ubiquitin ligase for Geminin to sustain hematopoietic stem cell activity.

Authors:  Motoaki Ohtsubo; Shin'ichiro Yasunaga; Yoshinori Ohno; Miyuki Tsumura; Satoshi Okada; Nobutsune Ishikawa; Kenichiro Shirao; Akira Kikuchi; Hideo Nishitani; Masao Kobayashi; Yoshihiro Takihara
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

10.  Geminin, a neuralizing molecule that demarcates the future neural plate at the onset of gastrulation.

Authors:  K L Kroll; A N Salic; L M Evans; M W Kirschner
Journal:  Development       Date:  1998-08       Impact factor: 6.868

View more
  15 in total

1.  Foxd4 is essential for establishing neural cell fate and for neuronal differentiation.

Authors:  Jonathan H Sherman; Beverly A Karpinski; Matthew S Fralish; Justin M Cappuzzo; Devinder S Dhindsa; Arielle G Thal; Sally A Moody; Anthony S LaMantia; Thomas M Maynard
Journal:  Genesis       Date:  2017-04-03       Impact factor: 2.487

Review 2.  Controlling centriole numbers: Geminin family members as master regulators of centriole amplification and multiciliogenesis.

Authors:  Marina Arbi; Dafni-Eleftheria Pefani; Stavros Taraviras; Zoi Lygerou
Journal:  Chromosoma       Date:  2017-12-14       Impact factor: 4.316

3.  High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas.

Authors:  Pramila Ramani; Emile Sowa-Avugrah; Margaret T May
Journal:  Virchows Arch       Date:  2015-07-22       Impact factor: 4.064

4.  Geminin facilitates FoxO3 deacetylation to promote breast cancer cell metastasis.

Authors:  Lei Zhang; Meizhen Cai; Zhicheng Gong; Bingchang Zhang; Yuanpei Li; Li Guan; Xiaonan Hou; Qing Li; Gang Liu; Zengfu Xue; Muh-Hua Yang; Jing Ye; Y Eugene Chin; Han You
Journal:  J Clin Invest       Date:  2017-04-24       Impact factor: 14.808

Review 5.  Genome Duplication: The Heartbeat of Developing Organisms.

Authors:  Melvin L DePamphilis
Journal:  Curr Top Dev Biol       Date:  2016-01-20       Impact factor: 4.897

6.  Geminin Is Essential for Pluripotent Cell Viability During Teratoma Formation, but Not for Differentiated Cell Viability During Teratoma Expansion.

Authors:  Diane C Adler-Wailes; Joshua A Kramer; Melvin L DePamphilis
Journal:  Stem Cells Dev       Date:  2016-11-07       Impact factor: 3.272

7.  High Glucose Inhibits Neural Stem Cell Differentiation Through Oxidative Stress and Endoplasmic Reticulum Stress.

Authors:  Xi Chen; Wei-Bin Shen; Penghua Yang; Daoyin Dong; Winny Sun; Peixin Yang
Journal:  Stem Cells Dev       Date:  2018-06-01       Impact factor: 3.272

8.  DNA Replication Inhibitor Geminin and Retinoic Acid Signaling Participate in Complex Interactions Associated With Pluripotency.

Authors:  Spyridon Champeris Tsaniras; George J Delinasios; Michalis Petropoulos; Andreas Panagopoulos; Athanasios K Anagnostopoulos; Maria Villiou; Dimitrios Vlachakis; Vasiliki Bravou; Georgios T Stathopoulos; Stavros Taraviras
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

9.  Gene regulatory networks in neural cell fate acquisition from genome-wide chromatin association of Geminin and Zic1.

Authors:  Savita Sankar; Dhananjay Yellajoshyula; Bo Zhang; Bryan Teets; Nicole Rockweiler; Kristen L Kroll
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

10.  Geminin deficiency enhances survival in a murine medulloblastoma model by inducing apoptosis of preneoplastic granule neuron precursors.

Authors:  Savita Sankar; Ethan Patterson; Emily M Lewis; Laura E Waller; Caili Tong; Joshua Dearborn; David Wozniak; Joshua B Rubin; Kristen L Kroll
Journal:  Genes Cancer       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.